Network International Holdings plc

DB:NIH Stock Report

Market Cap: €2.5b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Network International Holdings Valuation

Is NIH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NIH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NIH (€4.62) is trading above our estimate of fair value (€2.89)

Significantly Below Fair Value: NIH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NIH?

Key metric: As NIH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NIH. This is calculated by dividing NIH's market cap by their current earnings.
What is NIH's PE Ratio?
PE Ratio42.9x
EarningsUS$65.69m
Market CapUS$2.82b

Price to Earnings Ratio vs Peers

How does NIH's PE Ratio compare to its peers?

The above table shows the PE ratio for NIH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average20.8x
ARLN Aareal Bank
21.9xn/a€2.2b
ARLN Aareal Bank
13.7x24.6%€2.0b
HYQ Hypoport
38x28.9%€1.2b
GLJ Grenke
9.5x23.9%€708.6m
NIH Network International Holdings
42.9x30.4%€2.1b

Price-To-Earnings vs Peers: NIH is expensive based on its Price-To-Earnings Ratio (42.9x) compared to the peer average (27.7x).

Price to Earnings Ratio vs Industry

How does NIH's PE Ratio compare vs other companies in the European Diversified Financial Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
NIH 42.9xIndustry Avg. 11.2xNo. of Companies13PE01020304050+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NIH is expensive based on its Price-To-Earnings Ratio (42.9x) compared to the European Diversified Financial industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is NIH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NIH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio42.9x
Fair PE Ratio23.9x

Price-To-Earnings vs Fair Ratio: NIH is expensive based on its Price-To-Earnings Ratio (42.9x) compared to the estimated Fair Price-To-Earnings Ratio (23.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NIH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€4.36
0%
13.0%€5.01€3.46n/a4
Dec ’25n/a
€4.36
0%
13.0%€5.01€3.46n/a4
Nov ’25n/a
€4.36
0%
13.0%€5.01€3.46n/a4
Oct ’25n/a
€4.36
0%
13.0%€5.01€3.46n/a4
Sep ’25€4.60
€4.36
-5.3%
13.0%€5.01€3.46n/a4
Aug ’25€4.63
€4.41
-4.7%
12.4%€4.91€3.49n/a4
Jul ’25€4.50
€4.41
-2.0%
12.4%€4.91€3.49n/a4
Jun ’25€4.61
€4.41
-4.3%
12.4%€4.91€3.49n/a4
May ’25€4.61
€4.41
-4.2%
12.4%€4.91€3.49n/a4
Apr ’25€4.60
€4.37
-5.1%
11.7%€4.88€3.52n/a4
Mar ’25€4.48
€4.37
-2.5%
11.7%€4.88€3.52n/a4
Feb ’25€4.52
€4.37
-3.4%
11.7%€4.88€3.52n/a4
Jan ’25€4.48
€4.28
-4.5%
11.4%€4.77€3.48n/a4
Dec ’24€4.56
€4.30
-5.7%
11.2%€4.83€3.53n/a4
Nov ’24€4.46
€4.44
-0.3%
10.0%€4.95€3.61n/a5
Oct ’24€4.50
€4.52
+0.5%
9.6%€4.96€3.62n/a6
Sep ’24€4.52
€4.47
-1.2%
9.3%€4.83€3.52€4.607
Aug ’24€4.50
€4.37
-3.0%
9.8%€4.78€3.39€4.637
Jul ’24€4.46
€4.37
-2.0%
10.0%€4.83€3.42€4.507
Jun ’24€4.22
€4.41
+4.6%
9.9%€4.88€3.46€4.617
May ’24€4.38
€4.28
-2.3%
9.4%€4.65€3.38€4.617
Apr ’24€2.82
€4.45
+57.9%
14.2%€5.39€3.34€4.6010
Mar ’24€3.18
€4.60
+44.7%
13.6%€5.65€3.39€4.4810
Feb ’24€3.14
€4.69
+49.3%
9.4%€5.53€4.06€4.5210
Jan ’24€3.30
€4.77
+44.6%
12.2%€5.73€3.87€4.489

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/17 07:28
End of Day Share Price 2024/09/17 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Network International Holdings plc is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Orson RoutBarclays
Orson RoutBarclays
James GoodmanBarclays